Post-Partum Depression: A Clinical, Not Legal, Issue
(MedPage Today) -- California case has experts calling for better provider education
Publication date: Available online 20 May 2018 Source:Brain, Behavior, and Immunity Author(s): Michael S. Breen, Aliza P. Wingo, Nastassja Koen, Kirsten A. Donald, Mark Nicol, Heather J. Zar, Kerry J. Ressler, Joseph D. Buxbaum, Dan J. Stein Prenatal exposure to maternal stress and depression has been identified as a risk factor for adverse behavioral and neurodevelopmental outcomes in early childhood. However, the molecular mechanisms through which maternal psychopathology shapes offspring development remain poorly understood. We applied transcriptome-wide screens to 149 umbilical cord blood samples from neonates born to...
Kelsey Wells, 28, shared an Instagram post showing her transformation from after giving birth to now, four years later. A doctor suggested she deal with her depression with fitness.
This article provides evidence-based clinical best practices for the assessment and early recognition of postpartum depression, specifically in adolescents. In addition, suggestions for integration into practice and recommendations for interprofessional collaboration are discussed.
AbstractPurpose of ReviewNeuroactive steroid hormones, such as estradiol and progesterone, likely play a role in the pathophysiology of female-specific psychiatric disorders such as premenstrual dysphoric disorder (PMDD) and postpartum depression and may contribute to the marked sex differences observed in the incidence and presentation of affective disorders. However, few tools are available to study the precise contributions of these neuroactive steroids (NSs). In this review, we propose that the acoustic startle response (ASR), an objective measure of an organism ’s response to an emotional context or stressor, is...
Vicky Clayton cannot give her son the thing he wants most in the world - his dad.
Perinatal Mood and Anxiety Disorders (PMAD), including Antenatal Depression (AND) and Postpartum Depression (PPD), are one of the most common postpartum complications affecting 10-20% of perinatal women (Andersson et al., 2006; Cooper et al., 1988; Dietz et al., 2007; Evans et al., 2001; Gaynes et al., 2005; Josefsson et al., 2001; O ’Keane and Marsh, 2007). In severe cases, these disorders can be crippling (Abramowitz et al., 2010; Bernstein et al., 2008), and in developed nations, suicide is one of the largest contributors to maternal mortality (Palladino et al., 2011; Gentile, 2011; Oates, 2003; Lindahl et al., 2005).
Stress throughout the life-course is associated with a wide-range of adverse health outcomes. Accumulating evidence from animal and several human studies suggests that maternal distress and adversity experienced during pregnancy, including depression, anxiety, general and pregnancy-specific stress can increase the risk for impaired infant development.(Talge et al., 2007) Families in poverty, such as those participating in home visiting intervention programs, carry a high burden of adversity including increased early life stressors and family exposure to psychosocial stressors (e.g., violence, residential instability, food ...
Pregnancy and childbirth often trigger a depressive episode in women at risk. Postpartum depression (PPD) is a major mood disorder that occurs within 1 month of childbirth, and can last for months or even years. The prevalence of PPD ranges from approximately 10 –15%, but can be as high as 30% (Mann et al., 2010). Almost half of patients with postpartum disorders are not diagnosed or treated (Bloch et al., 2006). Untreated PPD affects not only mother's mental health, but also the development and behavior of infants (Grace et al., 2003).
The first treatment specifically for postpartum depression quickly decreases both moderate and severe symptoms of the condition, say two new phase 3 trials.Medscape Medical News